Close Menu

More articles about Microarrays & Multiplexing

Nanogen recently announced that Vance Randy White had been appointed chief executive officer and would replace company founder Howard Birndorf, who will remain chairman of the company’s board, a move that has signaled Nanogen’s efforts to accelerate its e

Agilent Technologies of Palo Alto, Calif., recently launched the Human 1 cDNA Microarray, its first commercially available human microarray.

What does the microarray world look like from the summit of the mountain?

Qiagen subsidiary Operon said it has discontinued sales of its pre-fabricated, medium-density OpArrays in North America, due to concerns that they might infringe on Affymetrix s patent portfolio.

Microarrays may be hot now, but in a few years, analysts say the market for these and other biochips will really begin to sizzle.

They can t be first. But Agilent Technologies, Incyte, and Corning all know they may be able to capture a share of the high-density microarray market by providing products researchers view as better than Affymetrix GeneChips, and each company is trying to figure out the magic formula for doing so.

AT A GLANCE: Received his PhD in molecular biology from UCLA in 1989. Worked with Michael Grunstein to examine the function of histone H4 in S. cerevisiae. Post-doctoral research at CalTech with Paul Sternberg, exploring gene function in C. elegans development.

This is a sample story for bio array news and mcirochips and arrays of all natures. If you want to go further we can go into all kinds of screwwy details about the following: ChipsDipsSpreadsSauces.You name it.

In the wake of the announcement that the working draft of the human genome sequence is done, BioInform spoke with four informatics

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.